Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 28
- 试验地点
- 2
- 主要终点
- Estimate the prevalence of SARS-CoV-2 infection in women with late fetal loss of unexplained cause.
研究概览
简要总结
Maternal-fetal transmission in the second or third trimester of pregnancy of the SARS-COV-2 virus could explain some late fetal losses.
Finding a cause in the context of fetal loss is essential for parents and caregivers. It helps to understand the history of the disease, to address the possible risk of a recurrence and to plan for future pregnancies.
If the maternal-fetal transmission of COVID 19 is confirmed and that it is responsible for obstetric complications, a preventive action could be proposed to the patients by the preconception vaccination.
The investigators are seeking to clarify the frequency of this transmission is information awaited by caregivers, women, couples in particular when the latter are in distress from late fetal loss.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- Single (Participant)
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Major patient
- •Patient with late spontaneous abortion (≥15 weeks of gestation)
- •Benefiting from a Social Security scheme
- •Patient who consented to participate in the study
- •Free subject, without tutorship, curatorship or subordination
排除标准
- •Persons not benefiting from a Social Security scheme or not benefiting from it through a third party.
- •Concurrent participation in another clinical research study.
结局指标
主要结局
Estimate the prevalence of SARS-CoV-2 infection in women with late fetal loss of unexplained cause.
时间窗: 2 months
Identification by PCR of the SARS-COV-2 virus in samples taken from the fetus
次要结局
未报告次要终点